{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:18:32Z","timestamp":1794694712981,"version":"4.9.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-026-02336-9","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T08:54:37Z","timestamp":1774601677000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Epidemiology, pharmacological treatment and invasive management of idiopathic intracranial hypertension in Austria: a nationwide, hospital-based, controlled analysis of insurance data"],"prefix":"10.1186","volume":"27","author":[{"given":"Nina","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nik","family":"Krajnc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Zaic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Macher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Marik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bertich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthold","family":"Pemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"W\u00f6ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthold","family":"Reichardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Bsteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"2336_CR1","doi-asserted-by":"publisher","unstructured":"Colman BD, Boonstra F, Nguyen MNL et al (2024) Understanding the pathophysiology of idiopathic intracranial hypertension (IIH): a review of recent developments. J Neurol Neurosurg Psychiatry 95(4):375. https:\/\/doi.org\/10.1136\/jnnp-2023-332222","DOI":"10.1136\/jnnp-2023-332222"},{"issue":"5","key":"2336_CR2","doi-asserted-by":"publisher","first-page":"e372","DOI":"10.1111\/j.1467-789X.2010.00799.x","volume":"12","author":"D Friesner","year":"2011","unstructured":"Friesner D, Rosenman R, Lobb BM, Tanne E (2011) Idiopathic intracranial hypertension in the USA: the role of obesity in establishing prevalence and healthcare costs. Obes Rev May 12(5):e372\u2013e380. https:\/\/doi.org\/10.1111\/j.1467-789X.2010.00799.x","journal-title":"Obes Rev May"},{"key":"2336_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/1874364101307010026","volume":"7","author":"J Best","year":"2013","unstructured":"Best J, Silvestri G, Burton B, Foot B, Acheson J (2013) The Incidence of Blindness Due to Idiopathic Intracranial Hypertension in the UK. Open Ophthalmol J 7:26\u201329. https:\/\/doi.org\/10.2174\/1874364101307010026","journal-title":"Open Ophthalmol J"},{"issue":"1","key":"2336_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/0022-510X(93)90084-C","volume":"116","author":"K Radhakrishnan","year":"1993","unstructured":"Radhakrishnan K, Thacker AK, Bohlaga NH, Maloo JC, Gerryo SE (1993) Epidemiology of idiopathic intracranial hypertension: A prospective and case-control study. J Neurol Sci 116(1):18\u201328. https:\/\/doi.org\/10.1016\/0022-510X(93)90084-C","journal-title":"J Neurol Sci"},{"issue":"10431","key":"2336_CR5","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","volume":"403","author":"NH Phelps","year":"2024","unstructured":"Phelps NH, Singleton RK, Zhou B et al (2024) Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet 403(10431):1027\u20131050. https:\/\/doi.org\/10.1016\/S0140-6736(23)02750-2","journal-title":"Lancet"},{"issue":"8","key":"2336_CR6","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1001\/archneur.1988.00520320065016","volume":"45","author":"FJ Durcan","year":"1988","unstructured":"Durcan FJ, Corbett JJ, Wall M (1988) The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol Aug 45(8):875\u2013877. https:\/\/doi.org\/10.1001\/archneur.1988.00520320065016","journal-title":"Arch Neurol Aug"},{"issue":"3","key":"2336_CR7","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41433-018-0238-5","volume":"33","author":"SP Mollan","year":"2019","unstructured":"Mollan SP, Aguiar M, Evison F, Frew E, Sinclair AJ (2019) The expanding burden of idiopathic intracranial hypertension. Eye (Lond) Mar 33(3):478\u2013485. https:\/\/doi.org\/10.1038\/s41433-018-0238-5","journal-title":"Eye (Lond) Mar"},{"issue":"9","key":"2336_CR8","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1001\/jamaneurol.2019.1812","volume":"76","author":"NJ Adderley","year":"2019","unstructured":"Adderley NJ, Subramanian A, Nirantharakumar K et al (2019) Association Between Idiopathic Intracranial Hypertension and Risk of Cardiovascular Diseases in Women in the United Kingdom. JAMA Neurol 76(9):1088\u20131098. https:\/\/doi.org\/10.1001\/jamaneurol.2019.1812","journal-title":"JAMA Neurol"},{"issue":"10","key":"2336_CR9","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1111\/j.1468-1331.2011.03372.x","volume":"18","author":"N Raoof","year":"2011","unstructured":"Raoof N, Sharrack B, Pepper IM, Hickman SJ (2011) The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK. Eur J Neurol Oct 18(10):1266\u20131268. https:\/\/doi.org\/10.1111\/j.1468-1331.2011.03372.x","journal-title":"Eur J Neurol Oct"},{"issue":"1\u20132","key":"2336_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00508-023-02252-x","volume":"136","author":"P Pruckner","year":"2024","unstructured":"Pruckner P, Mitsch C, Macher S et al (2024) The Vienna idiopathic intracranial hypertension database-An Austrian registry. Wien Klin Wochenschr Jan 136(1\u20132):32\u201339. https:\/\/doi.org\/10.1007\/s00508-023-02252-x","journal-title":"Wien Klin Wochenschr Jan"},{"issue":"9","key":"2336_CR11","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1136\/jnnp-2015-311302","volume":"87","author":"SP Mollan","year":"2016","unstructured":"Mollan SP, Ali F, Hassan-Smith G, Botfield H, Friedman DI, Sinclair AJ (2016) Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management. J Neurol Neurosurg Psychiatry 87(9):982\u2013992. https:\/\/doi.org\/10.1136\/jnnp-2015-311302","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"2336_CR12","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1038\/s41433-024-03140-y","volume":"38","author":"L Bonelli","year":"2024","unstructured":"Bonelli L, Menon V, Arnold AC, Mollan SP (2024) Managing idiopathic intracranial hypertension in the eye clinic. Eye 2024\/08\/01 38(12):2472\u20132481. https:\/\/doi.org\/10.1038\/s41433-024-03140-y","journal-title":"Eye 2024\/08\/01"},{"issue":"6","key":"2336_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/01658107.2014.956183","volume":"38","author":"SJ Hickman","year":"2014","unstructured":"Hickman SJ, Raoof N, Panesar H, McMullan JM, Pepper IM, Sharrack B (2014) Visual Outcomes from Shunting for Idiopathic Intracranial Hypertension. Neuroophthalmology 38(6):310\u2013319. https:\/\/doi.org\/10.3109\/01658107.2014.956183","journal-title":"Neuroophthalmology"},{"key":"2336_CR14","unstructured":"Statistik Austria (2025) Bev\u00f6lkerung im Jahresdurchschnitt seit 2002 nach Alter, Geschlecht sowie \u00f6sterreichischer\/ausl\u00e4ndischer Staatsangeh\u00f6rigkeit und Bundesland. https:\/\/www.statistik.at\/fileadmin\/pages\/404\/JDBev_Alter_Geschlecht_Staatsangeh_Bundesl_ab2002.ods"},{"issue":"9\u201310","key":"2336_CR15","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s002280000200","volume":"56","author":"M R\u00f8nning","year":"2000","unstructured":"R\u00f8nning M, Blix HS, Harb\u00f8 BT, Str\u00f8m H (2000) Different versions of the anatomical therapeutic chemical classification system and the defined daily dose\u2013are drug utilisation data comparable? Eur J Clin Pharmacol Dec 56(9\u201310):723\u2013727. https:\/\/doi.org\/10.1007\/s002280000200","journal-title":"Eur J Clin Pharmacol Dec"},{"issue":"10","key":"2336_CR16","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1111\/ene.13739","volume":"25","author":"G McCluskey","year":"2018","unstructured":"McCluskey G, Doherty-Allan R, McCarron P et al (2018) Meta-analysis and systematic review of population-based epidemiological studies in idiopathic intracranial hypertension. Eur J Neurol Oct 25(10):1218\u20131227. https:\/\/doi.org\/10.1111\/ene.13739","journal-title":"Eur J Neurol Oct"},{"issue":"18","key":"2336_CR17","doi-asserted-by":"publisher","first-page":"e1968","DOI":"10.1212\/wnl.0000000000201064","volume":"31","author":"NJ Adderley","year":"2022","unstructured":"Adderley NJ, Subramanian A, Perrins M, Nirantharakumar K, Mollan SP, Sinclair AJ, Headache (2022) Opiate Use, and Prescribing Trends in Women With Idiopathic Intracranial Hypertension: A Population-Based Matched Cohort Study. Neurol Oct 31(18):e1968\u2013e1978. https:\/\/doi.org\/10.1212\/wnl.0000000000201064","journal-title":"Neurol Oct"},{"issue":"2","key":"2336_CR18","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00415-022-11402-6","volume":"270","author":"M Thaller","year":"2023","unstructured":"Thaller M, Homer V, Hyder Y et al (2023) The idiopathic intracranial hypertension prospective cohort study: evaluation of prognostic factors and outcomes. J Neurol 270(2):851\u2013863. https:\/\/doi.org\/10.1007\/s00415-022-11402-6. \/02\/01 2023","journal-title":"J Neurol"},{"key":"2336_CR19","doi-asserted-by":"publisher","unstructured":"McCluskey G, Doherty-Allan R, McCarron P et al (2018) Meta-analysis and systematic review of population-based epidemiological studies in idiopathic intracranial hypertension. Eur J Neurol 25(10):1218\u20131227. https:\/\/doi.org\/10.1111\/ene.13739","DOI":"10.1111\/ene.13739"},{"issue":"12","key":"2336_CR20","doi-asserted-by":"publisher","first-page":"e2029669","DOI":"10.1001\/jamanetworkopen.2020.29669","volume":"3","author":"AG Hamedani","year":"2020","unstructured":"Hamedani AG, Thibault DP, Revere KE et al (2020) Trends in the Surgical Treatment of Pseudotumor Cerebri Syndrome in the United States. JAMA Netw Open 3(12):e2029669\u2013e2029669. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.29669","journal-title":"JAMA Netw Open"},{"issue":"10","key":"2336_CR21","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1136\/jnnp-2017-317440","volume":"89","author":"SP Mollan","year":"2018","unstructured":"Mollan SP, Davies B, Silver NC et al (2018) Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry Oct 89(10):1088\u20131100. https:\/\/doi.org\/10.1136\/jnnp-2017-317440","journal-title":"J Neurol Neurosurg Psychiatry Oct"},{"issue":"1","key":"2336_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s10194-018-0919-2","volume":"8","author":"J Hoffmann","year":"2018","unstructured":"Hoffmann J, Mollan SP, Paemeleire K, Lampl C, Jensen RH, Sinclair AJ (2018) European headache federation guideline on idiopathic intracranial hypertension. J Headache Pain Oct 8(1):93. https:\/\/doi.org\/10.1186\/s10194-018-0919-2","journal-title":"J Headache Pain Oct"},{"issue":"11","key":"2336_CR23","doi-asserted-by":"publisher","first-page":"e1090","DOI":"10.1212\/wnl.0000000000200839","volume":"13","author":"SP Mollan","year":"2022","unstructured":"Mollan SP, Mitchell JL, Yiangou A et al (2022) Association of Amount of Weight Lost After Bariatric Surgery With Intracranial Pressure in Women With Idiopathic Intracranial Hypertension. Neurol Sep 13(11):e1090\u2013e1099. https:\/\/doi.org\/10.1212\/wnl.0000000000200839","journal-title":"Neurol Sep"},{"issue":"6","key":"2336_CR24","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1001\/jamaneurol.2021.0659","volume":"1","author":"SP Mollan","year":"2021","unstructured":"Mollan SP, Mitchell JL, Ottridge RS et al (2021) Effectiveness of Bariatric Surgery vs Community Weight Management Intervention for the Treatment of Idiopathic Intracranial Hypertension: A Randomized Clinical Trial. JAMA Neurol Jun 1(6):678\u2013686. https:\/\/doi.org\/10.1001\/jamaneurol.2021.0659","journal-title":"JAMA Neurol Jun"},{"issue":"1","key":"2336_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s10194-023-01631-z","volume":"18","author":"N Krajnc","year":"2023","unstructured":"Krajnc N, Itariu B, Macher S et al (2023) Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension. J Headache Pain Jul 18(1):89. https:\/\/doi.org\/10.1186\/s10194-023-01631-z","journal-title":"J Headache Pain Jul"},{"issue":"13","key":"2336_CR26","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1212\/WNL.0b013e3182a55f17","volume":"81","author":"DI Friedman","year":"2013","unstructured":"Friedman DI, Liu GT, Digre KB (2013) Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 81(13):1159\u20131165. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a55f17","journal-title":"Neurology"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-026-02336-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02336-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02336-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T01:30:21Z","timestamp":1778031021000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10194-026-02336-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2336"],"URL":"https:\/\/doi.org\/10.1186\/s10194-026-02336-9","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NM: declares no conflict of interest relevant to this study. NK: has participated in meetings sponsored by, received speaker honoraria or travel funding from Alexion, BMS\/Celgene, Janssen-Cilag, Merck, Neuraxpharm, Novartis, Roche and Sanofi-Genzyme and held a grant for a Multiple Sclerosis Clinical Training Fellowship Programme from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). SZ: declares no conflict of interest relevant to this study. SM: declares no conflict of interest relevant to this study. WM: declares no conflict of interest relevant to this study. KN: declares no conflict of interest relevant to this study. MB: declares no conflict of interest relevant to this study. BP: has received honoraria for consultancy\/speaking from Chiesi, GenSight and Santen. CW: has received honoraria consultancy\/speaking from Apomedica, Curelator, Eli Lilly, Gr\u00fcnenthal, Hermes, Novartis, Pfizer, Ratiopharm\/Teva, and Stada. BR: declares no conflict of interest relevant to this study. GB: has participated in meetings sponsored by, received speaker honoraria or travel funding from Biogen, BMS, Heidelberg Engineering, Janssen, Lilly, Medwhizz, Merck, Neuraxpharm, Novartis, Roche, Sanofi, Teva and Zeiss, and received honoraria for consulting Adivo Associates, Biogen, BMS, Janssen, Merck, Novartis, Roche, Sanofi and Teva. He has received unrestricted research grants from BMS and Novartis. He serves on the Executive Committee of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and the Board of Directors of the International Multiple Sclerosis VisualSystem Consortium (IMSVISUAL).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"131"}}